Filing Details

Accession Number:
0001209191-16-125658
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-03 16:35:32
Reporting Period:
2016-06-01
Filing Date:
2016-06-03
Accepted Time:
2016-06-03 16:35:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
893949 Mednax Inc. MD Services-Hospitals (8060) 263667538
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1218834 M Joseph Calabro 1301 Concord Terrace
Sunrise FL 33323
President And Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-06-01 55,156 $0.00 253,882 No 4 A Direct
Common Stock Disposition 2016-06-01 28,347 $67.78 228,981 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 13,789 additional shares based on the achievement of certain performance-based criteria for the period from April 1, 2016 through March 31, 2017. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on June 1, 2017, June 1, 2018 and June 1, 2019.
  2. Sales made pursuant to Reporting Person's 10b5-1 trading plan.
  3. Sales of shares were made in sixty-four separate transactions with prices ranging from $67.56 to $67.95 for a weighted average sales price of $67.781.
  4. Includes 3,446 restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with achievement in excess of target of specified performance-based criteria for the performance period from April 1, 2015 through March 31, 2016, which restricted shares were not previously reported. The additional restricted shares vest in three equal installments on June 1, 2016, June 1, 2017 and June 1, 2018, subject to continued employment.